The regimen and Drug Administratio...

The regimen and Drug Administration may be short-staffed across the coming year, a cautionary report from the clumps Center for the Study of put drugs into Development warns.
FDA will have to work onward bioterrorism countermeasures, handle increasingly entangled new product applications, and render certain that approved drugs are marketed appropriately--and not bought from Canada.
Added to these challenges is a staff of older experienced employee who will be retiring or moving to other positions. And with fewer recent Drug Applications being submitted, the FDA might not have the bundle to staff each ...

Guinea Calling Cards